Wealth Enhancement Advisory Services, LLC Repligen Corp Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Repligen Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 4,118 shares of RGEN stock, worth $486,212. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,118
Previous 4,045
1.8%
Holding current value
$486,212
Previous $582,000
10.14%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
494Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$894 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$893 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$600 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$199 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$198 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.55B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....